Home
About
Overview
Sharing Data
ORCID
Help
History (38)
Development and psychometric testing of the Nurse Practitioner Primary Care Organizational Climate Questionnaire.
Decade-Long Trends in Liver Transplant Waitlist Removal Due to Illness Severity: The Impact of Centers for Medicare and Medicaid Services Policy.
Hypoperfusion Index Ratio is Associated with Early Neurological Deficit Severity and Decline after Mechanical Thrombectomy in Large Vessel Occlusion Ischemic Stroke (P2-5.004).
Parents Caring For Adult Children With Serious Mental Illness.
Benefits and harms of roflumilast in moderate to severe COPD.
See All 38 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Benefits and harms of roflumilast in moderate to severe COPD.
Yu T, Fain K, Boyd CM, Singh S, Weiss CO, Li T, Varadhan R, Puhan MA. Benefits and harms of roflumilast in moderate to severe COPD. Thorax. 2014 Jul; 69(7):616-22.
View in:
PubMed
subject areas
Aged
Aminopyridines
Benzamides
Cyclopropanes
Female
Humans
Male
Middle Aged
Phosphodiesterase 4 Inhibitors
Placebos
Pulmonary Disease, Chronic Obstructive
Risk Assessment
authors with profiles
Sonal Singh MD, MPH